In assessing risk of hormone therapy for menopause, dose -- not form -- matters

(University of California - Los Angeles Health Sciences) UCLA-led research finds that the way estrogen therapy for menopause is delivered doesn't affect risk or benefit. What DOES make a difference with the commonly used conjugated equine estrogen, plus progestogen, is dosage.

https://www.eurekalert.org/pub_releases/2017-07/uoc--iar072617.php

Source: EurekAlert! - Cancer - July 26, 2017 Category: Cancer & Oncology Source Type: news